Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial
Centre d'Investigation Clinique de Nantes · Institut Català d'Oncologia · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,587
total citations
- FWCI
- 74.12
- Percentile
- 100%
- References
- 20
Citations per year
Authors
22- JDJean‐Yves DouillardCorresponding
Centre d'Investigation Clinique de Nantes
- RRRafael Rosell
Institut Català d'Oncologia, Hospital Universitari Germans Trias i Pujol
- MDMario De Lena
Istituti di Ricovero e Cura a Carattere Scientifico
- FCFrancesco Carpagnano
Ospedale San Paolo
- RRRodryg Ramlau
Instytut Gruźlicy i Chorób Płuc
Topics & keywords
Topics
Keywords
- Medicine
- Vinorelbine
- Internal medicine
- Hazard ratio
- Neutropenia
- Lung cancer
- Chemotherapy
- Clinical endpoint
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.